Predictive factors for treatment responses to baricitinib in severe alopecia areata: A retrospective, multivariate analysis of 70 cases from a single centerMoyuka Wada‐Irimada, Yoshihide Asano, Takehiro Takahashi et al.|The Journal of Dermatology|2025Cited by 15
A retrospective study evaluating the outcomes of high‐dose methylprednisolone pulse therapy for 483 patients with moderate‐to‐severe alopecia areataMoyuka Wada‐Irimada, Kenshi Yamasaki, Masato Mizuashi et al.|British Journal of Dermatology|2021Cited by 14
Biologics modulate antinuclear antibodies, immunoglobulin E, and eosinophil counts in psoriasis patientsRiichiro Sugiura, Kenshi Yamasaki, Emi Yamazaki et al.|The Journal of Dermatology|2021Cited by 11
IL-23 Expression in Stewart-Treves Syndrome: Two Case Reports and Immunohistochemical InvestigationSaaya Yoshida, Setsuya Aiba, Taku Fujimura et al.|Case Reports in Oncology|2020Cited by 7
Ritlecitinib in Alopecia Areata: A 24‐Week Real‐World Experience Contrasting <scp>JAK</scp> Inhibitor‐Naïve and <scp>JAK</scp> Inhibitor‐Experienced PatientsToshiki Okazaki, Yoshihide Asano, Takehiro Takahashi et al.|The Journal of Dermatology|2025Cited by 5